On Thursday, August 31st, Chordate Medical will release its interim report for Q2 2023. On the same day at 2 PM, the company will hold a webcast presentation and Q&A session with CEO Anders Weilandt and Västra Hamnen Corporate Finance. The presentation will be conducted in Swedish and can be followed via computer or mobile devices.
To register for the web conference, please sign up using the following link: https://attendee.gotowebinar.com/register/5303405709530509661
The number of spots is limited, so we recommend registering well in advance to secure your spot.
For more information, please contact:
Anders Weilandt, CEO
Cell: +46 733-874277